In agreement with our flow cytometry findings, we found that DYRK1A inhibition leads to increase in expression of G1/S regulators (i.e. Cyclin D1, and CDK4) and a decrease in expression of CENP-A in tumor samples. The gene discussed is CENPA; the disease is neoplasm.